Rankings
▼
Calendar
MLYS
Mineralys Therapeutics, Inc.
$2B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-1.48
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$19,000
← FY 2022
All Quarters
Q2 2022 →
MLYS Q1 2022 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
